- Home
- PGNY
PGNY
Progyny Inc.
as 08-05-2025 4:00pm EST
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.
Upcoming Earnings Alert:
Get ready for potential market movements as Progyny Inc. PGNY prepares to release earnings report on 07 Aug 2025.
| Founded: | 2008 | Country: | United States |
| Employees: | N/A | City: | NEW YORK |
| Market Cap: | 2.0B | IPO Year: | 2019 |
| Target Price: | $24.00 | AVG Volume (30 days): | 900.6K |
| Analyst Decision: | Buy | Number of Analysts: | 8 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.57 | EPS Growth: | -7.16 |
| 52 Week Low/High: | $13.39 - $26.76 | Next Earning Date: | 08-07-2025 |
| Revenue: | $1,213,181,000 | Revenue Growth: | 9.46% |
| Revenue Growth (this year): | 7.61% | Revenue Growth (next year): | 11.39% |
Stock Insider Trading Activity of Progyny Inc. (PGNY)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Scott Cheryl | PGNY | Director | Jun 11 '25 | Sell | $22.07 | 2,675 | $59,037.25 | 14,112 |
Latest Progyny Inc. News
PGNY Breaking Stock News: Dive into PGNY Ticker-Specific Updates for Smart Investing
StockStory
a month ago
1 Stock Under $50 with Exciting Potential and 2 to Question
Argus Research
a month ago
PGNY: Lowering target price to $23.00
GlobeNewswire
a month ago
Progyny Adds Pelvic Floor Therapy, Continuing to Close Gaps in Care Across Women’s Health
Zacks
a month ago
GeneDx Holdings (WGS) Moves 19.0% Higher: Will This Strength Last?
StockStory
2 months ago
1 Small-Cap Stock on Our Watchlist and 2 to Turn Down
Argus Research
2 months ago
PGNY: Raising target price to $25.00
GlobeNewswire
2 months ago
Progyny Joins Amazon’s Health Benefits Connector Program as First Women’s Health and Family Building Solution
GlobeNewswire
2 months ago
Progyny Adds Distinguished Healthcare Executive Elizabeth Bierbower to Board of Directors
Compare PGNY vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PGNY Progyny Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.